CN103330911B - Chinese medicine powder for treating coronary heart disease and preparation method thereof - Google Patents
Chinese medicine powder for treating coronary heart disease and preparation method thereof Download PDFInfo
- Publication number
- CN103330911B CN103330911B CN201310235381.7A CN201310235381A CN103330911B CN 103330911 B CN103330911 B CN 103330911B CN 201310235381 A CN201310235381 A CN 201310235381A CN 103330911 B CN103330911 B CN 103330911B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- preparation
- medicine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 79
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 35
- 239000000843 powder Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims description 35
- 239000009636 Huang Qi Substances 0.000 claims abstract description 19
- 108010052008 colla corii asini Proteins 0.000 claims abstract description 19
- 241000217407 Margaritifera Species 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 16
- 241000972155 Moschus Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 31
- 210000002216 heart Anatomy 0.000 abstract description 13
- 239000000463 material Substances 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 244000138993 panchioli Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 25
- 239000008280 blood Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 18
- 244000153234 Hibiscus abelmoschus Species 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 210000004072 lung Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 206010002383 Angina Pectoris Diseases 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 210000000038 chest Anatomy 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 239000003826 tablet Substances 0.000 description 10
- 206010008479 Chest Pain Diseases 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 239000002775 capsule Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 206010061876 Obstruction Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000036770 blood supply Effects 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 210000004351 coronary vessel Anatomy 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 230000000149 penetrating effect Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000010125 myocardial infarction Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000756943 Codonopsis Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000218176 Corydalis Species 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 239000000006 Nitroglycerin Substances 0.000 description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000032023 Signs and Symptoms Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000009912 gualou xiebai baijiutang Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000242759 Actiniaria Species 0.000 description 1
- 241000271039 Agkistrodon Species 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 206010007513 Cardiac aneurysm Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241000283956 Manis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 206010033664 Panic attack Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000237636 Pheretima Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 241000131808 Scolopendra Species 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- -1 electuary Substances 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000011726 slow pulse Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Chinese medicine powder for treating a coronary heart disease. The traditional Chinese medicine powder is prepared from the following raw medicinal materials in parts by weight: 6-15 parts of radix curcumae, 20-45 parts of barley malt, 2-6 parts of dalbergia wood, 6-15 parts of radix ophiopogonis, 12-18 parts of nacre mother of pearl, 2-8 parts of agilawood, 9-25 parts of Polygonum cuspidatum, 3-9 parts of Platycodon grandiflorum, 2-6 parts of Sanguis draconis, 6-12 parts of colla corii asini, 5-12 parts of radix polygonati officinalis, 2-6 parts of American ginseng, 20-45 parts of radix astragali, 2-6 parts of stigma croci, 20-45 parts of Salvia miltiorrhiza, 20-45 parts of trichosanthes kirilowii and 0.03-0.1 part of musk. The Chinese medicine powder has the excellent effects that the selected materials are all traditional Chinese medicines and are free of any toxic and side effects; the prescriptions are completely in conformity with principles of the traditional Chinese medicines and mind-body characteristics of heart patients, and the different prescriptions have different functions aiming at different crowds on the premise of a total principle; and medicinal resources are easily available, the cost of the medicinal materials are low, and the burden on patients can be relieved.
Description
The application is divisional application: original bill application number: 201210091229.1, the applying date: 2012.3.31, denomination of invention: Chinese medicine composition for the treatment of coronary heart disease and preparation method thereof.
Technical field
The present invention relates to traditional Chinese medicine field, particularly relate to a kind of Chinese medicine composition for the treatment of coronary heart disease and preparation method thereof.
Background technology
Coronary atherosclerotic heart disease (hereinafter referred to as coronary heart disease) causes the heart disease caused by myocardial ischemia, anoxia due to selenium shape atherosclerosis.And more than 95% myocardial infarction is many is formed by developing coronary heart disease, and acute myocardial infarction mortality rate is very high, mostly 30% ~ 40%, is serious threat human life, healthy commonly encountered diseases.
Coronary heart disease generally belongs to the category such as the traditional Chinese medical science " thoracic obstruction ", " precordial pain with cold limbs ", " angina pectoris ".Just on the books in Huangdi's Internal Classics: " discomfort and fullness in the hypochondrium, pain over the hypochondrium, bears pain between back of the body shoulder blade for pained person, chest pain." and for example " Ling Shu Miraculous Pivot or Divine Axis faint disease " section say: " angina pectoris, bluish colour of the limbs extending up to the elbows and knees, very pained.Onset of disease in the morning and dying in the evening, onset of disease in the evening and dying in the next morning." quite similar angina pectoris and myocardial infarction.Han dynasty Zhang Zhongjing has been made a series of arteries and veins card further and has been described in chapters such as " Medical Treasures of the Golden Chamber obstruction of qi in the chest and cardialgia lose heart abnormal pulse card control ", and proposes the square medicine of comparison system.As " pain over the chest and back, loses heart, pulse at CUN KOU being deep and slow, GUAN being pulse faint, tense and rapid, Gualou Xiebai Baijiu Tang for the disease of the thoracic obstruction, dyspnea and expectoration "; And for example " unable to tie down due to obstruction of QI in the chest, chest pain radiating to the back person, Gualou Xiebai Banxia Tang master it ".Ancient Chinese medicine doctor plays all to some extent to dialectical, square medicine on this basis, in long term medical practice, have accumulated the clinical experience that coronary heart disease prevented and treated by a whole set of Chinese medicine.
Modern TCM is to the research of coronary heart disease, and clinical article sees nineteen fifty-five the earliest, proposes primary disease and is equivalent to the traditional Chinese medical science it " thoracic obstruction ", " angina pectoris ".The fifties based on case introduction, Clinical Exploration and basic research few.The sixties, clinical data increased gradually, set forth to some extent, and achieve preliminary efficacy, but basic research is still little to the etiology and pathogenesis, therapeutic rules, differentiation of symptoms and signs for classification of syndrome, treatment side's medicine etc. of primary disease; To clinical data and the theoretic discussion showed increased seventies, constantly holding of national academic conference, facilitates research work development, curative effect is improved constantly.Chinese medicine is not only applied to control angina pectoris, also for rescuing acute myocardial infarction.This Tou summarizes more clinical experience period, and explores Therapy regularity.Method for the treatment of has determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, cipher prescription, folk prescription proved recipe, acupuncture, massage etc.The rule for the treatment of has blood circulation promoting and blood stasis dispelling, activate yang a surname numbness, aromatic herbs activating YANG and invigorating Qi, benefiting QI for activating blood circulation and righting the kidney invigorating etc.Unanimously generally acknowledge in dialectical and mostly belong to syndrome of intermingled deficiency and excess, internal organs virtual loss functional disorder be this, and blood stasis, the stagnation of QI, expectorant are turbid, cold coagulation numbness resistance heart arteries and veins is for marking.Form of Chinese drug, is the main quick-effective preparation and the expansion blood vessel Chinese medicine that develop into sheet, cream, ball, electuary, aerosol and injection, particularly allevating angina pectoris from decoction, substantially increases the clinical value for the treatment of coronary disease with traditional Chinese medicine.Acute myocardial infarction is rescued in the combination of Chinese and Western medicine makes the case fatality rate of primary disease be down to about 12% from 30% ~ 40%.Basic research aspect, finds that activating blood and removing stasis Method and blood circulation promoting medicine have increase coronary flow, reduces myocardial oxygen consumption, anticoagulant and anticoagulant and thrombolytic, the effect of protection ischemic myocardium.Since the eighties, though the excavation of the new method of new drug is not many, affirmed curative effect further to existing side's medicine, further investigation pharmacological action and analysis effective ingredient are done a lot of work.As inquired into the mechanism of action of the blood circulation promoting and blood stasis dispelling rule for the treatment of from aspect researchs such as hemorheology, microcirculation and cardiac inspections, and carry out antiatherogenic research etc.
Publication number CN 1498645A(application number 02148326.4) Chinese patent literature disclose one and be used for the treatment of cerebral infarction sequela and coronary heart disease Chinese medicinal capsule and manufacture method thereof, this Chinese medicinal capsule is by Pheretima 15-20 gram, eupolyphage sece steleophaga 15-20 gram, Scorpio 25-30 gram, Scolopendra 25-30 gram, Rhizoma Typhonii 15-20 gram, Agkistrodon 15-20 gram, Rhizoma Gastrodiae 15-20 gram, Ganoderma 15-20 gram, Bombyx Batryticatus 15-20 gram, Hirudo 25-30 gram, Squama Manis 20-30 gram processed, Moschus 10-15 gram, Radix Ginseng Rubra 15-0 gram, Radix Curcumae 15-20 gram, Rhizoma Chuanxiong 15 1 20 grams, Radix Salviae Miltiorrhizae 25 1 30 grams, Rhizoma Corydalis 15 1 20 grams composition.Publication number CN 101524521 A(application number 200810101486.2) Chinese patent literature disclose a kind of Chinese medicine composition for the treatment of coronary heart disease, be made up of Radix Glycyrrhizae Preparata, Rhizoma Polygonati Odorati, the Radix Paeoniae Alba, Cortex Acanthopancis, Radix Ophiopogonis, Radix Codonopsis, long-pending reality, Poria, Rhizoma Zingiberis, Endothelium Corneum Gigeriae Galli, Ramulus Cinnamomi, the Radix Rehmanniae, Radix Bupleuri, Colla Corii Asini, Radix Stephaniae Tetrandrae, CHUANSHAO, Radix Adenophorae (Radix Glehniae), Herba Leonuri, Radix Angelicae Sinensis, Radix Astragali Preparata and/or pharmaceutically acceptable carrier.Authorization Notice No. CN 1970069(application number 200610170280.6) Chinese patent literature disclose a kind of medicine pill for the treatment of coronary heart disease, it is with 30 kinds of Chinese herbal medicine such as the Radix Astragali, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Herba Taxilli, Fructus Trichosanthis, Rhizoma Corydalis, Radix Paeoniae, Rhizoma Anemones Altaicae, Caulis Spatholobi, Rhizoma Polygonati, Semen Sesami Nigrum, Semen Cuscutae, the Rhizoma Atractylodis Macrocephalae, Radix Curcumae, Radix Polygoni Multiflori Preparata, Herba Epimedii, Semen Ziziphi Spinosae, Fructus Schisandrae Chinensis, Colla Corii Asini, Ganoderma, Poria, Rhizoma Sparganii, Rhizoma Curcumae, Radix Ophiopogonis, Concha Ostreae, Radix Codonopsis, Lignum Santali Albi, Radix Glycyrrhizaes for raw material, is modulated by pulverizing interpolation Mel.
In a word, Chinese medicine achieves good curative effect in treatment primary disease, but also there are some problems: desirable not enough to the quick-acting vasodilative effects of acute blood supply insufficiency clinically, the Electrocardiographic curative effect of improvement is had much room for improvement, to the Predisposing factor preventing and treating coronary heart disease, as hypertension, hyperlipemia, diabetes also need synchronous research, further raising is also awaited to arrhythmia such as the curative effect such as premature beat, atrial fibrillation that coronary heart disease occurs.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide and a kind ofly prepare simple, taking convenience, be easy to carry, the Chinese medicine composition and preparation method thereof of the easy treatment coronary heart disease of clothes for a long time.This Chinese medicine composition determined curative effect and having no side effect.
Technical scheme of the present invention is:
The Chinese medicine composition for the treatment of myocardial infarction, is prepared from by following bulk drugs, is weight portion: Radix Curcumae 6-15, Fructus Hordei Germinatus 20-45, Lignum Dalbergiae Odoriferae 2-6, Radix Ophiopogonis 6-15, Concha Margaritifera 12-18, Lignum Aquilariae Resinatum 2-8, Rhizoma Polygoni Cuspidati 9-25, Radix Platycodonis 3-9, Sanguis Draxonis 2-6, Colla Corii Asini 6-12, Rhizoma Polygonati Odorati 5-12, Radix Panacis Quinquefolii 2-6, Radix Astragali 20-45, Stigma Croci 2-6, Radix Salviae Miltiorrhizae 20-45, Fructus Trichosanthis 20-45, Moschus 0.03-0.1.
In preferred scheme, Radix Curcumae 9-12, Fructus Hordei Germinatus 25-40, Lignum Dalbergiae Odoriferae 3-5, Radix Ophiopogonis 9-12, Concha Margaritifera 14-16, Lignum Aquilariae Resinatum 3-6, Rhizoma Polygoni Cuspidati 12-20, Radix Platycodonis 4-6, Sanguis Draxonis 3-5, Colla Corii Asini 8-10, Rhizoma Polygonati Odorati 6-10, Radix Panacis Quinquefolii 3-5, Radix Astragali 25-40, Stigma Croci 3-5, Radix Salviae Miltiorrhizae 25-40, Fructus Trichosanthis 25-40, Moschus 0.05-0.08.
Be more preferably, Radix Curcumae 10, Fructus Hordei Germinatus 30, Lignum Dalbergiae Odoriferae 4, Radix Ophiopogonis 10, Concha Margaritifera 15, Lignum Aquilariae Resinatum 4, Rhizoma Polygoni Cuspidati 16, Radix Platycodonis 5, Sanguis Draxonis 4, Colla Corii Asini 9, Rhizoma Polygonati Odorati 8, Radix Panacis Quinquefolii 4, the Radix Astragali 35, Stigma Croci 4, Radix Salviae Miltiorrhizae 35, Fructus Trichosanthis 35, Moschus 0.06.
Present invention also offers the preparation method aforementioned Chinese medicine composition being made pharmaceutically acceptable water preparation, powder, tablet or capsule.
The preparation method of described water preparation is:
(1) Radix Curcumae, Fructus Hordei Germinatus, Lignum Dalbergiae Odoriferae, Radix Ophiopogonis, Concha Margaritifera, Lignum Aquilariae Resinatum, Rhizoma Polygoni Cuspidati, Radix Platycodonis, Sanguis Draxonis, Colla Corii Asini, Rhizoma Polygonati Odorati, Radix Panacis Quinquefolii, the Radix Astragali, Stigma Croci, Radix Salviae Miltiorrhizae and Fructus Trichosanthis are pulverized, cross 120-140 mesh sieve (preferably 130 mesh sieves), obtain fine powder;
(2) by step (1) gained fine powder mix homogeneously, be placed in penetrating bag, soak 6-8 hour (preferably 7 hours) with the cold water that temperature is 20-40 DEG C (preferably 30 DEG C), water consumption is 3-4 times (preferably 3.5 times) of described fine powder weight;
(3) be heated to boiling, continue 0.6-1.2 hour (preferred 0.8-1.0 hour) and take out penetrating bag afterwards, gained liquid, through being concentrated into the 1/2-1/3 of original volume, obtains concentrated solution;
(4) add in the concentrated solution of step (3) gained after being ground by Moschus, sterile packaged, obtains Chinese medicine composition water preparation.
The preparation method of described powder is: each crude drug was pulverized 60-100 mesh sieve (preferred 80-85 mesh sieve), and obtained Chinese medicine powder.
The preparation method of described tablet is: by claim 6 gained Chinese medicine powder according to 0.2-0.3g/ sheet (preferred 0.25g/ sheet) metering, be pressed into circular or other forms of tablet dosage form according to the preparation for processing of tablet.
The preparation method of described tablet is: by claim 6 gained Chinese medicine powder according to 0.2-0.3g/ grain (preferred 0.25g/ grain) metering, be processed into capsule shape dosage form according to the preparation for processing of capsule.
Present invention also offers the application of described Chinese medicine composition when preparing treatment myocardial infarction, myocardial necrosis, anginal medicine.
The pharmacology of the present invention's main raw material of Chinese medicine used is as follows:
Concha Margaritifera: nature and flavor: salty, cold.Gui Jing: return liver, heart channel.Effect: suppressing the hyperactive liver and subsiding YANG, arresting convulsion improving eyesight.Cure mainly: dizzy for having a headache. irritated insomnia, liver-heat conjunctival congestion, deficiency of the liver blurred vision." Chinese medicine voluminous dictionary ": this thing (Concha Margaritifera) double enter the heart, liver two warp, enter Liver Channel from Concha Haliotidis person be different, therefore relate to mind patient, this.
Lignum Aquilariae Resinatum: nature and flavor: pungent, bitter, tepor.Gui Jing: return spleen, stomach, kidney channel.Effect: promoting the circulation of QI to relieve pain, warming middle-JIAO to arrest vomiting, helping inspiration to relieve asthma.Cure mainly: for the vexed pain of breast abdominal distention, gastrofrigid vomiting singultus, QI rising in reverse order of suffering from a deficiency of the kidney dyspnea with rapid respiration.
Rhizoma Polygoni Cuspidati: nature and flavor: micro-hardship, is slightly cold.Gui Jing: return liver, gallbladder, lung meridian.Effect: expelling wind and removing dampness, dissipating blood stasis analgesic therapy, relieving cough and resolving phlegm.Cure mainly: for arthralgia, jaundice due to damp-heat, amenorrhea ， mass in the abdomen, burn due to hot liquid or fire, injury from falling down, carbuncle sore tumefacting virus, cough with copious phlegm.
Radix Platycodonis: nature and flavor: bitter, pungent is flat.Gui Jing: return lung meridian.Effect: lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.Cure mainly: for cough with copious phlegm, uncomfortable in chest smooth, pharyngalgia, hoarseness, lung abscess vomiting pus, skin infection difficulty in discharging of pus.
Sanguis Draxonis: nature and flavor: sweet, salty is flat.Gui Jing: GUIXIN, Liver Channel.Effect: removing blood stasis and relieving pain, hemostasia and promoting granulation.Cure mainly: lose for falling to flutter, ecchymoma due to internal injury; Continuous bleeding due to traumatic injury.
Colla Corii Asini: nature and flavor: sweet is flat.Gui Jing: return lung, liver, kidney channel.Effect: YIN nourishing of enriching blood, moisturizes, hemostasis.Cure mainly: for blood deficiency and yellow complexion, dizzy cardiopalmus, flesh flaccidity is unable, dysphoria and insomnia, stirring-up of pathogenic wind in the interior resulting from deficiency, xeropulmonary cough, and chronic cough is spat blood, haematemesis hematuria, metrorrhagia of having blood in stool, vaginal bleeding during pregnancy.
Rhizoma Polygonati Odorati: nature and flavor: sweet, is slightly cold.Gui Jing: attach to the lung and stomach meridians.Effect: nourishing YIN to relieve dryness, promoting the production of body fluid to quench thirst.Cure mainly: for lung stomach-Yin wound, cough caused by dryness-heat, swallow in thirsty, interior-heat is quenched one's thirst.
Radix Panacis Quinquefolii: sweet, the micro-hardship of property is cool.GUIXIN, lung, kidney channel.There is effect of boosting qi and nourishing yin, clearing away heat and promoting production of body fluid.Lose for deficiency of vital energy the moon, interior-heat, cough with asthma expectorant blood, deficiency-heat is tired of tired, quenches one's thirst, dryness of the mouth and throat.Radix Panacis Quinquefolii has the effect of resisting fatigue, antioxidation, anti-stress, anticoagulant, reduction blood coagulability, in addition, diabetics is also had to the effect regulating blood glucose.
The Radix Astragali: property is sweet, tepor.Return lung, spleen, liver, kidney channel.There is effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema.Be generally used for the treatment deficiency of vital energy weak, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst, chronic nephritis, albuminuria, diabetes etc.
Stigma Croci: nature and flavor: sweet is flat.Gui Jing: GUIXIN, Liver Channel.Effect: blood circulation promoting and blood stasis dispelling, removing pathogenic heat from blood and toxic substance from the body, resolving stagnation for tranquilization.Cure mainly: for amenorrhea and mass in the abdomen, postpartum stagnation, maculae caused by violent heat pathogen, melancholy painful abdominal mass is vexed, and palpitation with fear is gone mad.
Radix Salviae Miltiorrhizae: nature and flavor are bitter, cold nature.Energy blood circulation promoting and blood stasis dispelling, removing heat from blood, calms the nerves.Enter the heart, spleen two warp.According to " book on Chinese herbal medicine is looked for the truth ": Radix Salviae Miltiorrhizae has the effect into percardium removing blood stasis with potent drugs.Modern medicine study confirms, its energy coronary artery dilator, increases coronary flow, improve myocardial ischemia, infraction and cardiac function, regulate the rhythm of the heart, and can expand peripheral blood vessel, improve microcirculation; Body's hypoxia tolerance can be improved; There is anticoagulation, promote fibrinolytic, suppress platelet aggregation, the effect of inhibition thrombosis; Can blood fat be reduced, suppress coronary atherosclerosis to be formed; The convalescent period of erythrocyte and hematochrome can be shortened, Reticulocyte is increased, the reparation organized can be promoted, accelerate the healing of fracture; Nervus centralis is had to have inhibitory action; There is antitumor action; Energy enhancing human body immunity function; Blood glucose can be reduced; Inhibitory action is had to various bacteria such as tubercule bacillus.
Radix Ophiopogonis: nature and flavor: sweet, micro-hardship, is slightly cold.Gui Jing: GUIXIN, lung, stomach warp.Effect: YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.Cure mainly: for dryness of the lung dry cough.Chronic consumptive disease is coughed, and Tianjin wound is thirsty, vexed insomnia, and interior-heat is quenched one's thirst, dryness of the intestine constipation; Pharyngeal diphtheria.
Fructus Trichosanthis (son): cold in nature, sweet in the mouth, micro-hardship.Return lung, stomach, large intestine channel.Clearing away heat and eliminating phlegm, relieving stuffiness of the chest by dispersing aggregation of pathogens, moisturizes laxation.For cough due to lung-heat, the turbid Huang of expectorant is thick, obstruction of qi in the chest and cardialgia, blocked-up chest feeling of fullness, acute mastitis, lung abscess, and acute appendicitis swells and ache, constipation.Modern medicine and pharmacology research proves: Fructus Trichosanthis has expansion heart arteria coronaria, increases coronary flow effect; Significant protective effect is had to acute myocardial ischemia.
Radix Curcumae: property is pungent, bitter, cold.Return liver, the heart, lung meridian.Can regulating qi to disperse stagnation, heart fire-clearing upset-relieving, promoting the function of the gallbladder to alleviate jaundice.Be generally used for amenorrhea dysmenorrhea, chest and abdomen swelling and pain, twinge, calentura coma, epilepsy is gone mad, jaundice dark coloured urine.
Lignum Dalbergiae Odoriferae: property is pungent, temperature.Return liver, spleen channel.There is promoting flow of QI and blood, pain relieving, hemostasia effect.Be generally used for epigastric pain, hypochondriac pain due to stagnation of liverQI, thoracic obstruction twinge, injury from falling down, traumatic hemorrhage.
Fructus Hordei Germinatus nature and flavor: sweet are flat.Gui Jing: return spleen, stomach warp.Effect: spleen benefiting and stimulating the appetite, moves back newborn relieving distension.Cure mainly: do not disappear for food stagnation, women's ablactation, Fructus Hordei Germinatus (parched to brown) relieving dyspepsia.Do not disappear for food stagnation, abdominal distention.
Moschus (preferred natural Moschus): nature and flavor: pungent, temperature.Gui Jing: GUIXIN, spleen channel.Effect: refreshment of having one's ideas straightened out, promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain.Cure mainly: for calentura coma, apoplexy syncope due to accumulation of phlegm, stagnation of QI sudden syncope, attacked by pestiferous factors is gone into a coma, amenorrhea ， mass in the abdomen, difficult labour stillborn fetus, trusted subordinate's sudden pain, carbuncle scrofula, and laryngopharynx swelling and pain, falls and flutter the pain of injury, and arthralgia pain is numb.
Chinese medicine composition scientific formula provided by the invention, the preparation method of various dosage form is simple, products obtained therefrom taking convenience, is easy to carry.In addition, excellent results of the present invention also shows:
1,selected materials is all Chinese medicine material, without any side effects;
2,this prescription meets Chinese medicine principle and cardiac's body and mind feature completely, under the prerequisite of general principle, can have different prescription according to different crowd, and function is different.
3,medicine source is easy to get, and medical material is with low cost, can relieve patient ' s burden.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not limited thereto.
embodiment 1the Chinese medicine composition for the treatment of coronary heart disease, is prepared from by following bulk drugs: Radix Curcumae 6g, Fructus Hordei Germinatus 20 g, Lignum Dalbergiae Odoriferae 2 g, Radix Ophiopogonis 6 g, Concha Margaritifera 12 g, Lignum Aquilariae Resinatum 2 g, Rhizoma Polygoni Cuspidati 9 g, Radix Platycodonis 3 g, Sanguis Draxonis 2 g, Colla Corii Asini 6 g, Rhizoma Polygonati Odorati 5 g, Radix Panacis Quinquefolii 2 g, the Radix Astragali 20 g, Stigma Croci 2 g, Radix Salviae Miltiorrhizae 20 g, Fructus Trichosanthis 20 g, Moschus 0.03 g.
The preparation method of the Chinese medicine composition water preparation of above-mentioned treatment coronary heart disease:
(1) Radix Curcumae, Fructus Hordei Germinatus, Lignum Dalbergiae Odoriferae, Radix Ophiopogonis, Concha Margaritifera, Lignum Aquilariae Resinatum, Rhizoma Polygoni Cuspidati, Radix Platycodonis, Sanguis Draxonis, Colla Corii Asini, Rhizoma Polygonati Odorati, Radix Panacis Quinquefolii, the Radix Astragali, Stigma Croci, Radix Salviae Miltiorrhizae and Fructus Trichosanthis are pulverized, cross 140 mesh sieves, obtain fine powder;
(2) by step (1) gained fine powder mix homogeneously, be placed in penetrating bag, soak 8 hours with the cold water that temperature is 40 DEG C, water consumption is 4 times of described fine powder weight;
(3) be heated to boiling, continue to take out penetrating bag after 1.2 hours, gained liquid, through being concentrated into the 1/2-1/3 of original volume, obtains concentrated solution;
(4) add in the concentrated solution of step (3) gained after being ground by Moschus, sterile packaged, obtains Chinese medicine composition water preparation.
The instructions of taking of water preparation of the present invention: water preparation is 7 days courses for the treatment of, takes every day twice (warm), each 350m1-500m1.
embodiment 2the Chinese medicine composition for the treatment of coronary heart disease, is prepared from by following bulk drugs: Radix Curcumae 15g, Fructus Hordei Germinatus 45 g, Lignum Dalbergiae Odoriferae 6 g, Radix Ophiopogonis 15 g, Concha Margaritifera 18 g, Lignum Aquilariae Resinatum 8 g, Rhizoma Polygoni Cuspidati 25 g, Radix Platycodonis 9 g, Sanguis Draxonis 6 g, Colla Corii Asini 12 g, Rhizoma Polygonati Odorati 12 g, Radix Panacis Quinquefolii 6 g, the Radix Astragali 45 g, Stigma Croci 6 g, Radix Salviae Miltiorrhizae 45 g, Fructus Trichosanthis 45 g, Moschus 0.1 g.
The preparation method of the Chinese medicine powder for the treatment of coronary heart disease is: each crude drug was pulverized 100 mesh sieves, obtains Chinese medicine powder, and powder was divided 0.4g/ bag.Adopt every day 2-3 time, each one bag, with warm boiled water, 7 days courses for the treatment of.
Model case: xxx, the age: 46 years old; Sex: women; Main suit: intermittent chest pain 3 months; History of present illness: patient occurred without obvious inducement chest pain before 6 hours is pain vexed after breastbone, and in persistence, the radiation of companion's back part, without abdominal distention, without stomachache, without nausea and vomiting, without fear of cold heating, without cough and expectoration.Discuss: the blood supply of electrocardio diagram coronary artery is obviously not enough, through checking the basic chest pain got rid of other reasons and cause, caused by coronary heart disease, chest pain diagnosis is clear and definite.
Take the Chinese medicine powder of the present embodiment gained treatment coronary heart disease, each one bag, every day 2 times, warm boiled water, 7 days courses for the treatment of.Take 21 days, chest pain obviously alleviates, and confusingly in the heart also alleviates, and the amount of receiving increases, spirit can, take 1 month, symptom is eliminated, peace of sleeping night, vexedly removes, and strength increases, receive food can, there is not any discomfort when patient takes in following the service 2 months, patient's self-induction is fully recovered.
embodiment 3the Chinese medicine composition for the treatment of coronary heart disease, is prepared from by following bulk drugs: Radix Curcumae 9g, Fructus Hordei Germinatus 25 g, Lignum Dalbergiae Odoriferae 3 g, Radix Ophiopogonis 9 g, Concha Margaritifera 14 g, Lignum Aquilariae Resinatum 3 g, Rhizoma Polygoni Cuspidati 12 g, Radix Platycodonis 4 g, Sanguis Draxonis 3 g, Colla Corii Asini 8 g, Rhizoma Polygonati Odorati 6 g, Radix Panacis Quinquefolii 3 g, the Radix Astragali 25 g, Stigma Croci 3 g, Radix Salviae Miltiorrhizae 25 g, Fructus Trichosanthis 25 g, Moschus 0.05 g.
The preparation method of the Chinese medicine composition tablet for the treatment of coronary heart disease is: each crude drug was pulverized 60 mesh sieves, obtain Chinese medicine powder, by gained Chinese medicine powder according to the metering of 0.25g/ sheet, be pressed into circular or other forms of tablet dosage form according to the preparation for processing of tablet.Tablet adopts twice daily, each 2-4 sheet, with warm boiled water, and 7 days courses for the treatment of.
Model case: xxx, male, 56 years old.Precordial dull pain is had a surplus for 2 years, and every day, panic attacks 2-5 time, could alleviate containing nitroglycerin.Have uncomfortable in chest, be afraid of cold, cardiopalmus, extremities being not warm be warm, fatigue and weak, lower limb swells the diseases such as the soreness of waist, chest pain radiating to the back.Electrocardio diagram coronary insufficiency.B ultrasonic display merges ventricular aneurysm.Deep-slow pulse, white and thin fur.
Take the Chinese medicine composition tablet of the present embodiment gained treatment coronary heart disease, adopt twice daily, each 4, with warm boiled water, 7 days courses for the treatment of.Take 21 days, precordialgia obviously alleviates, and fatigue and weak also alleviates, and the amount of receiving increases, spirit can, take 1 month, the coronary artery blood supply of electrocardio diagram obviously improves, and following the service 4 months, patient fully recovers.
embodiment 4the Chinese medicine composition for the treatment of coronary heart disease, is prepared from by following bulk drugs: Radix Curcumae 12g, Fructus Hordei Germinatus 40 g, Lignum Dalbergiae Odoriferae 5 g, Radix Ophiopogonis 12 g, Concha Margaritifera 16 g, Lignum Aquilariae Resinatum 6 g, Rhizoma Polygoni Cuspidati 20 g, Radix Platycodonis 6 g, Sanguis Draxonis 5 g, Colla Corii Asini 10 g, Rhizoma Polygonati Odorati 10 g, Radix Panacis Quinquefolii 5 g, the Radix Astragali 40 g, Stigma Croci 5 g, Radix Salviae Miltiorrhizae 40 g, Fructus Trichosanthis 40 g, Moschus 0.08 g.
The preparation method of the Chinese medicinal composition capsules agent for the treatment of coronary heart disease is: each crude drug was pulverized 80 mesh sieves, obtain Chinese medicine powder, by gained Chinese medicine powder according to the metering of 0.25g/ grain, be processed into capsule shape dosage form according to the preparation for processing of capsule.
Model case: xxx, 60 years old, man, more acutely and frequently angina pectoris is there is one day, the anginosus time is longer, and inducement is not obvious, takes nitroglycerin, but weak curative effect, with Nausea and vomiting, profuse sweating, bradycardia, acute cardiac insufficiency, severe arrhythmia during angina pectoris attacks.
Take the Chinese medicinal composition capsules agent of the present embodiment gained treatment coronary heart disease, adopt twice daily, each 4, with warm boiled water, 7 days courses for the treatment of.Take 21 days, angina pectoris obviously alleviates, Nausea and vomiting transference cure, and the amount of receiving increases, spirit can, take 1 month, the coronary artery blood supply of electrocardio diagram obviously improves, and following the service 3 months, patient fully recovers.
embodiment 5the Chinese medicine composition for the treatment of coronary heart disease, is prepared from by following bulk drugs: Radix Curcumae 10g, Fructus Hordei Germinatus 30 g, Lignum Dalbergiae Odoriferae 4 g, Radix Ophiopogonis 10 g, Concha Margaritifera 15 g, Lignum Aquilariae Resinatum 4 g, Rhizoma Polygoni Cuspidati 16 g, Radix Platycodonis 5 g, Sanguis Draxonis 4 g, Colla Corii Asini 9 g, Rhizoma Polygonati Odorati 8 g, Radix Panacis Quinquefolii 4 g, the Radix Astragali 35 g, Stigma Croci 4 g, Radix Salviae Miltiorrhizae 35 g, Fructus Trichosanthis 35 g, Moschus 0.06 g.
The preparation method of the Chinese medicine composition water preparation for the treatment of coronary heart disease is:
(1) Radix Curcumae, Fructus Hordei Germinatus, Lignum Dalbergiae Odoriferae, Radix Ophiopogonis, Concha Margaritifera, Lignum Aquilariae Resinatum, Rhizoma Polygoni Cuspidati, Radix Platycodonis, Sanguis Draxonis, Colla Corii Asini, Rhizoma Polygonati Odorati, Radix Panacis Quinquefolii, the Radix Astragali, Stigma Croci, Radix Salviae Miltiorrhizae and Fructus Trichosanthis are pulverized, cross 130 mesh sieves, obtain fine powder;
(2) by step (1) gained fine powder mix homogeneously, be placed in penetrating bag, soak 7 hours with the cold water that temperature is 30 DEG C, water consumption is 3.5 times of described fine powder weight;
(3) be heated to boiling, continue to take out penetrating bag after 1.0 hours, gained liquid, through being concentrated into the 1/2-1/3 of original volume, obtains concentrated solution;
(4) add in the concentrated solution of step (3) gained after being ground by Moschus, sterile packaged, obtains Chinese medicine composition water preparation.
test example 1the clinical practice of Chinese medicine composition water preparation of embodiment 5 gained treatment coronary heart disease: in June, 2008 in December ,-2011, screen 120 routine patients in 4 hospitals, wherein women 58 example, male 62 example, oldest 72 years old, minimal ages 38 years old, 55.2 years old mean age.Before test 2 weeks, Continuous Observation is carried out to this crowd, record symptom and change, be divided into two groups at random, experimental group and matched group, experimental group takes embodiment 5 products obtained therefrom, and matched group takes other medicine (conventional medication such as metoprolol, lignocaine, norepinephrine).Using method is: take every day twice (warm), each 350m1-500m1(adjusts to some extent depending on concrete condition), 7 days courses for the treatment of.Curative effect situation criterion: cure: take a course for the treatment of of this product, the blood supply of electrocardio diagram coronary artery obviously improves, and malaise symptoms disappears, and energy and muscle power obviously strengthen; Effective: to take a course for the treatment of of this product, the blood supply of electrocardio diagram artery chronic improves, and malaise symptoms alleviates or partial disappearance, and energy and muscle power strengthen; Invalid: take a course for the treatment of of this product, malaise symptoms is unchanged.Result is as shown in table 1.
Table 1: take embodiment 5 product 38-72 year Treatment in Patients with Coronary Heart result
| Experimental group | Matched group | |
| Number of cases | 100 | 20 |
| Male's number of cases | 52 | 10 |
| Women's number of cases | 48 | 10 |
| Age (year) | 38-72 | 38-72 |
| Clinical cure number of cases | 72 | 5 |
| Effective number of cases | 27 | 11 |
| Invalid number of cases | 1 | 4 |
| Total effective rate | 99% | 80% |
Therapeutic effect: cure 72 examples (72%), effective 27 examples (27%), invalid 1 example (1%), total effective rate 99%.Successful is better than matched group.
Take period self-induction symptom and physical change of spirit as shown in table 2.
Table 2:
The present invention selects Radix Panacis Quinquefolii, Fructus Trichosanthis, Radix Curcumae, Fructus Hordei Germinatus, Lignum Dalbergiae Odoriferae etc. to carry out compatibility, produces synergism, more effectively can treat coronary heart disease after making these drug regimens.In side, Radix Salviae Miltiorrhizae, Radix Curcumae, Lignum Dalbergiae Odoriferae, Stigma Croci master are at blood circulation promoting and blood stasis dispelling, removing obstruction in the collateral to relieve pain; Radix Panacis Quinquefolii, the Radix Astragali, Radix Ophiopogonis Replenishing QI and nourishing YIN, hold up this training unit; Fructus Trichosanthis a surname numbness the chest stuffiness relieving; Moschus is warded off and dirtyly to be had one's ideas straightened out.Concha Margaritifera, Lignum Aquilariae Resinatum, Rhizoma Polygoni Cuspidati, Radix Platycodonis, Sanguis Draxonis, Rhizoma Polygonati Odorati are used for the vexed pain of breast abdominal distention, expelling wind and removing dampness, dissipating blood stasis analgesic therapy, nourishing YIN to relieve dryness; Colla Corii Asini nourishing blood YIN nourishing.All medicines share, and invigorate blood circulation and can yin nourishing, blood stasis dispelling and just do not hinder, and have one's ideas straightened out and QI invigorating of holding concurrently, therefore can obtain good therapeutic effect.Take 10 days, more than 53% feel takes a turn for the better to some extent, and malaise symptoms improves; Take 20 days, more than 72% feel takes a turn for the better to some extent, and malaise symptoms improves or disappears, and spirit, muscle power strengthen; Take 30 days, more than 97% feel takes a turn for the better to some extent, and malaise symptoms improves or disappears, and spirit, muscle power strengthen, and the blood supply of electrocardio diagram coronary artery obviously improves, and some patients self-induction is fully recovered.Take more than 30 days in experimental group, effective percentage can reach 93%, and matched group is only 76%.
The prescription of the application is distinguished veteran doctors of TCM proved recipe, and have passed through the demonstration of Liaocheng University, Liaocheng City hospital of traditional Chinese hospital experts and scholars, has the prospect of industrialized implementation.Present inventor is Shandong institute of political science and law employee (speaker's inventive science), and completing of this invention has benefited from Shandong Province 12 Planning emphasis subject---the support of Law of Economy subject fund.
It should be pointed out that detailed description of the invention is the more representational example of the present invention, obvious technical scheme of the present invention is not limited to above-described embodiment, can also have a lot of distortion.Those of ordinary skill in the art, with the present invention clear and definite disclosed or according to undoubted the obtaining of the written description of file, the claimed scope of this patent all should be thought.
Claims (4)
1. treat the preparation method of the Chinese medicine powder of coronary heart disease, it is characterized in that, be prepared from by following bulk drugs, be weight portion: Radix Curcumae 6-15, Fructus Hordei Germinatus 20-45, Lignum Dalbergiae Odoriferae 2-6, Radix Ophiopogonis 6-15, Concha Margaritifera 12-18, Lignum Aquilariae Resinatum 2-8, Rhizoma Polygoni Cuspidati 9-25, Radix Platycodonis 3-9, Sanguis Draxonis 2-6, Colla Corii Asini 6-12, Rhizoma Polygonati Odorati 5-12, Radix Panacis Quinquefolii 2-6, Radix Astragali 20-45, Stigma Croci 2-6, Radix Salviae Miltiorrhizae 20-45, Fructus Trichosanthis 20-45, Moschus 0.03-0.1, step is as follows: each crude drug was pulverized 60-100 mesh sieve, obtains Chinese medicine powder.
2. preparation method as claimed in claim 1, is characterized in that, Radix Curcumae 9-12, Fructus Hordei Germinatus 25-40, Lignum Dalbergiae Odoriferae 3-5, Radix Ophiopogonis 9-12, Concha Margaritifera 14-16, Lignum Aquilariae Resinatum 3-6, Rhizoma Polygoni Cuspidati 12-20, Radix Platycodonis 4-6, Sanguis Draxonis 3-5, Colla Corii Asini 8-10, Rhizoma Polygonati Odorati 6-10, Radix Panacis Quinquefolii 3-5, Radix Astragali 25-40, Stigma Croci 3-5, Radix Salviae Miltiorrhizae 25-40, Fructus Trichosanthis 25-40, Moschus 0.05-0.08.
3. preparation method as claimed in claim 1, is characterized in that, Radix Curcumae 10, Fructus Hordei Germinatus 30, Lignum Dalbergiae Odoriferae 4, Radix Ophiopogonis 10, Concha Margaritifera 15, Lignum Aquilariae Resinatum 4, Rhizoma Polygoni Cuspidati 16, Radix Platycodonis 5, Sanguis Draxonis 4, Colla Corii Asini 9, Rhizoma Polygonati Odorati 8, Radix Panacis Quinquefolii 4, the Radix Astragali 35, Stigma Croci 4, Radix Salviae Miltiorrhizae 35, Fructus Trichosanthis 35, Moschus 0.06.
4. the preparation method as described in any one of claim 1-3, is characterized in that, each crude drug was pulverized 80-85 mesh sieve.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310235381.7A CN103330911B (en) | 2012-03-31 | 2012-03-31 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310235381.7A CN103330911B (en) | 2012-03-31 | 2012-03-31 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210091229 Division CN102614462B (en) | 2012-03-31 | 2012-03-31 | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103330911A CN103330911A (en) | 2013-10-02 |
| CN103330911B true CN103330911B (en) | 2014-12-17 |
Family
ID=49239161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310235381.7A Active CN103330911B (en) | 2012-03-31 | 2012-03-31 | Chinese medicine powder for treating coronary heart disease and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103330911B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105381408A (en) * | 2015-12-15 | 2016-03-09 | 刘学来 | Compound preparation for treating trigeminal neuralgia and preparation method thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | A kind of Tongxinluo medicinal composition and its application |
| CN101417086A (en) * | 2008-12-03 | 2009-04-29 | 青岛市市立医院 | Traditional Chinese medicine preparation for treating myocardial ischemia |
| CN101524521A (en) * | 2008-03-07 | 2009-09-09 | 天科仁祥技术（北京）有限责任公司 | Chinese medicinal composition for treating coronary heart disease and preparation method thereof |
| CN101711850A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method |
| CN101874891A (en) * | 2010-04-26 | 2010-11-03 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating heart-throb and preparation method thereof |
| CN102210839A (en) * | 2011-05-29 | 2011-10-12 | 曹莹莹 | Traditional Chinese medicine capsule for treating coronary heart disease |
-
2012
- 2012-03-31 CN CN201310235381.7A patent/CN103330911B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | A kind of Tongxinluo medicinal composition and its application |
| CN101524521A (en) * | 2008-03-07 | 2009-09-09 | 天科仁祥技术（北京）有限责任公司 | Chinese medicinal composition for treating coronary heart disease and preparation method thereof |
| CN101417086A (en) * | 2008-12-03 | 2009-04-29 | 青岛市市立医院 | Traditional Chinese medicine preparation for treating myocardial ischemia |
| CN101711850A (en) * | 2009-10-26 | 2010-05-26 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method |
| CN101874891A (en) * | 2010-04-26 | 2010-11-03 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating heart-throb and preparation method thereof |
| CN102210839A (en) * | 2011-05-29 | 2011-10-12 | 曹莹莹 | Traditional Chinese medicine capsule for treating coronary heart disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103330911A (en) | 2013-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104740289A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN102648946A (en) | Warm compression thermal therapy liquid and preparation method thereof | |
| CN102058870A (en) | Medicine for treating rheumatism, rheumatoid arthritis and stroke hemiplegia and preparation method thereof | |
| CN104173773A (en) | Preparation with functions of treating migraine, dispelling wind and promoting blood circulation and preparation methods | |
| CN102008674B (en) | Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof | |
| CN102614460B (en) | Traditional Chinese medicine composition for treating myocardial infarction and preparation method thereof | |
| CN103463467B (en) | A kind of seedling prescription wine with nourishing kidney yin | |
| CN102210839A (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN103330911B (en) | Chinese medicine powder for treating coronary heart disease and preparation method thereof | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN103705733A (en) | A traditional Chinese medicine capsule for treating arrhythmia and preparation method thereof | |
| CN102614462A (en) | Traditional Chinese medicine composition for treating coronary heart disease and preparation method thereof | |
| CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
| CN102614461B (en) | Spray for rapidly relieving stenocardia and preparation method thereof | |
| CN105727001A (en) | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
| CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN102614459B (en) | Traditional Chinese medicine spray for rapidly curing myocardial ischemia and preparation method thereof | |
| CN103285327B (en) | Traditional Chinese medicine composition tablet for treating coronary heart diseases and preparation method thereof | |
| CN102626485A (en) | Pure Chinese medicine preparation for treating hypertension | |
| CN105194478A (en) | Powder being used for treating coronary heart diseases and having function of promoting blood circulation to remove meridian obstruction | |
| CN105748911A (en) | Side reaction resisting capsule for postoperative tumor patients and preparation method thereof | |
| CN104288378A (en) | Traditional Chinese medicine for treating deficiency constipation | |
| CN103536883B (en) | The Chinese medicine for the treatment of heart kidney qi Yin bivacuity pattern of syndrome spleen fatiguing disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LIU LINBO Free format text: FORMER OWNER: LI HAOCHENG Effective date: 20140811 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Fengying Inventor after: Lv Shuyun Inventor after: Zhang Yongliang Inventor after: Li Jing Inventor before: Li Haocheng |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250014 JINAN, SHANDONG PROVINCE TO: 266000 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI HAOCHENG TO: LI FENGYING LV SHUYUN ZHANG YONGLIANG LI JING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140811 Address after: 266000 Shandong Province, Qingdao city Nanjing Road No. 2 Applicant after: Liu Linbo Address before: 2, building 5, building 250014, modern leisure city, 34-1 Jiefang East Road, Lixia District, Shandong City, Ji'nan province 1001 Applicant before: Li Haocheng |
|
| ASS | Succession or assignment of patent right |
Owner name: HAN XIAOFENG Free format text: FORMER OWNER: LIU LINBO Effective date: 20141114 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Han Xiaofeng Inventor after: Feng Bo Inventor after: Hu Peng Inventor before: Li Fengying Inventor before: Lv Shuyun Inventor before: Zhang Yongliang Inventor before: Li Jing |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI FENGYING LV SHUYUN ZHANG YONGLIANG LI JING TO: HAN XIAOFENG FENG BO HU PENG Free format text: CORRECT: ADDRESS; FROM: 266000 QINGDAO, SHANDONG PROVINCE TO: 256600 BINZHOU, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20141114 Address after: 661 Affiliated Hospital of Binzhou Medical College, two the Yellow River Road, Binzhou, Shandong 256600, China Applicant after: Han Xiaofeng Address before: 266000 Shandong Province, Qingdao city Nanjing Road No. 2 Applicant before: Liu Linbo |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HAIMEN JINQILIN ROSEWOOD INVESTMENT AND DEVELOPMEN Free format text: FORMER OWNER: HAN XIAOFENG Effective date: 20150423 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 256600 BINZHOU, SHANDONG PROVINCE TO: 226100 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150423 Address after: 226100 Nantong, Haimen City, Haimen City, Hai Tong Road, No. 207 Patentee after: Haimen Jinqilin Rosewood Investment and Development Co., Ltd. Address before: 661 Affiliated Hospital of Binzhou Medical College, two the Yellow River Road, Binzhou, Shandong 256600, China Patentee before: Han Xiaofeng |